Joyce Mhlanga

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

Susan Chi, P. Mickey Williams, Sinchita Roy‐Chowdhuri et al. · JNCI Journal of the National Cancer Institute · 2023 · 91 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial

Olive S. Eckstein, Carl E. Allen, P. Mickey Williams et al. · Journal of Clinical Oncology · 2022 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

TBCRC 008: Early Change in ¹⁸F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2–Negative Primary Operable Breast Cancer

Roisín M. Connolly, Jeffrey P. Leal, Matthew P. Goetz et al. · Journal of Nuclear Medicine · 2014 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry

Joyce Mhlanga, Daniel J. Durand, Hua-Ling Tsai et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 47 citations

Medicine, Oncology, Molecular Imaging +7

Dynamic Multi-Bed FDG PET imaging: Feasibility and optimization

Nicolas A. Karakatsanis, Martin A. Lodge, Yun Zhou et al. · 2011 · 40 citations

Medicine, Nuclear Medicine, Radiology +17